References
- Hess L, Riesenberg K, Rolston KVI, et al. Administrating an additional hepatitis B vaccination dose after 18 years maintains adequate long-term protection levels in healthcare workers. Infect Dis. 2020;52(5):330–335.
- Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68–75.
- Van Damme P. Long-term protection after hepatitis B vaccine. J Infect Dis. 2016;214(1):1–3.
- Wang Z-Z, Gao Y-H, Lu W, et al. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Hum Vaccin Immunother. 2017;13(4):909–915.
- Coppola N, Corvino AR, De Pascalis S, et al. The long-term immunogenicity of recombinant hepatitis B virus (HVC) vaccine: contribution of universal HBV vaccination in Italy. BMC Infect Dis. 2015;15(1):149.
- Meireles LC, Marinho RT, Van Damme P. Three decades of hepatitis B control with vaccination. World J Hepatol. 2015;7(18):2127–2132.
- John TJ, Cooksley G. Steering Committee for the Prevention and Control of Infectious Diseases in Asia. Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations? J Gastroenterol Hepatol. 2005;20(1):5–10.
- Bruce MG, Bruden D, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214(1):16–22.
- Anderson CL, Remschmidt C, Drobnitzky F-P, et al. Hepatitis B immune status in adolescents vaccinated during infancy: a retrospective cohort study from a pediatric practice in Germany. Hum Vacc Immunother. 2016;12(3):779–784.
- Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Syst Rev. 2016;2016(6):CD008256.